Alzheimer Europe welcomed delegates from 22 member organisations to its Public Affairs meeting on 3 June 2025 in Brussels (Belgium). The session was moderated by Alzheimer Europe Chairperson Maria do Rosário Zincke dos Reis (Portugal) and the agenda covered two main topic areas: The first part looked at “Preparing for new AD treatments in Europe” and was led by Director for Research Angela Bradshaw, who gave attendees some background on developments around anti-amyloid therapies for Alzheimer’s disease (AD), shared Alzheimer Europe’s recent activities around these therapies and then discussed some of the next steps. Following her presentation, members were invited to share learnings from national activities and campaigns in this area. The second part of the meeting covered Alzheimer Europe activities on brain health and dementia risk reduction.
Up first, Project Officer Lukas Duffner shared some of the initial findings from the SHARE survey, which looks to examine the prevalence of risk factors across countries in Europe. He then invited members to discuss whether they felt this survey was useful to their work, which additional subgroups they suggested to examine and how results should be presented, once available. Angela Bradshaw then took the floor again, to give an update on our work on various research projects and the up-coming Dementia in Europe magazine supplement on brain health scheduled for October. Delegates were then invited to discuss priorities for brain health and risk reduction at the EU level, before the meeting closed. The next Public Affairs meeting is scheduled for 2 and 3 December, and will again take place in Brussels.
